1. Home
  2. RZLT vs DKL Comparison

RZLT vs DKL Comparison

Compare RZLT & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • DKL
  • Stock Information
  • Founded
  • RZLT 2010
  • DKL 2012
  • Country
  • RZLT United States
  • DKL United States
  • Employees
  • RZLT N/A
  • DKL N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • DKL Natural Gas Distribution
  • Sector
  • RZLT Health Care
  • DKL Energy
  • Exchange
  • RZLT Nasdaq
  • DKL Nasdaq
  • Market Cap
  • RZLT 361.3M
  • DKL 2.3B
  • IPO Year
  • RZLT N/A
  • DKL N/A
  • Fundamental
  • Price
  • RZLT $4.86
  • DKL $43.75
  • Analyst Decision
  • RZLT Strong Buy
  • DKL Buy
  • Analyst Count
  • RZLT 6
  • DKL 4
  • Target Price
  • RZLT $12.00
  • DKL $44.25
  • AVG Volume (30 Days)
  • RZLT 1.3M
  • DKL 99.5K
  • Earning Date
  • RZLT 05-13-2025
  • DKL 08-05-2025
  • Dividend Yield
  • RZLT N/A
  • DKL 10.15%
  • EPS Growth
  • RZLT N/A
  • DKL 7.97
  • EPS
  • RZLT N/A
  • DKL 2.98
  • Revenue
  • RZLT N/A
  • DKL $938,491,000.00
  • Revenue This Year
  • RZLT $35.39
  • DKL $21.19
  • Revenue Next Year
  • RZLT N/A
  • DKL N/A
  • P/E Ratio
  • RZLT N/A
  • DKL $14.68
  • Revenue Growth
  • RZLT N/A
  • DKL N/A
  • 52 Week Low
  • RZLT $2.22
  • DKL $34.59
  • 52 Week High
  • RZLT $6.19
  • DKL $45.71
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 69.67
  • DKL 61.99
  • Support Level
  • RZLT $4.15
  • DKL $42.05
  • Resistance Level
  • RZLT $4.71
  • DKL $43.50
  • Average True Range (ATR)
  • RZLT 0.28
  • DKL 0.95
  • MACD
  • RZLT 0.03
  • DKL -0.08
  • Stochastic Oscillator
  • RZLT 96.74
  • DKL 81.78

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.

Share on Social Networks: